middle.news
Starpharma Accelerates Partnerships and Hits Record Viraleze™ Sales in Q2 FY26
10:32am on Thursday 29th of January, 2026 AEDT
•
Biotechnology
Read Story
Starpharma Accelerates Partnerships and Hits Record Viraleze™ Sales in Q2 FY26
10:32am on Thursday 29th of January, 2026 AEDT
Key Points
Advancement of key partnerships with Genentech, Medicxi, and Radiopharm Theranostics
Preclinical radiopharmaceutical program nearing clinical trial initiation
Record online sales month for Viraleze™ with 70% year-to-date growth
Received USD $5.5 million upfront payment from Genentech
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
STARPHARMA HOLDINGS (ASX:SPL)
OPEN ARTICLE